tiprankstipranks
Matinas BioPharma (MTNB)
XASE:MTNB
US Market
MTNB
Matinas BioPharma
RESEARCH TOOLSreports

Matinas BioPharma (MTNB) Financial Statements

1,537 Followers

Matinas BioPharma Financial Overview

Matinas BioPharma's market cap is currently $3.22M. The company's EPS TTM is $-1.031; its P/E ratio is -0.42; Matinas BioPharma is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.10M$ 3.19M$ 33.00K
Gross Profit$ 0.00$ 0.00$ 1.10M$ -13.49M$ -14.55M
Operating Income$ -6.96M$ -24.59M$ -23.77M$ -24.59M$ -24.73M
EBITDA$ -6.50M$ -19.19M$ -22.82M$ -24.23M$ -24.45M
Net Income$ -10.35M$ -24.25M$ -22.94M$ -21.00M$ -23.28M
Balance Sheet
Cash & Short-Term Investments$ 4.00M$ 7.28M$ 13.76M$ 28.81M$ 49.62M
Total Assets$ 7.21M$ 12.64M$ 25.10M$ 78.87M$ 61.33M
Total Debt$ 1.35M$ 2.89M$ 3.56M$ 4.12M$ 4.70M
Net Debt$ -2.65M$ -4.39M$ -1.23M$ -2.76M$ -16.33M
Total Liabilities$ 2.38M$ 5.05M$ 5.86M$ 42.23M$ 8.83M
Stockholders' Equity$ 4.83M$ 7.59M$ 19.25M$ 36.64M$ 52.49M
Cash Flow
Free Cash Flow$ -7.01M$ -15.88M$ -15.50M$ -20.05M$ -15.48M
Operating Cash Flow$ -7.01M$ -15.88M$ -15.28M$ -19.16M$ -15.22M
Investing Cash Flow$ 335.00K$ 9.21M$ 13.24M$ 4.88M$ 16.77M
Financing Cash Flow$ 3.39M$ 9.17M$ -7.00K$ 79.00K$ 6.96M
Currency in USD

Matinas BioPharma Earnings and Revenue History

Income Statement >

Matinas BioPharma Debt to Assets

Balance Sheet >

Matinas BioPharma Cash Flow

Cash Flow >

Matinas BioPharma Forecast EPS vs Actual EPS

Earnings >